{
  "ticker": "REGN",
  "year": 2023,
  "quarter": 2,
  "last_updated": "2025-04-15T14:53:27.739286",
  "count": 12,
  "transactions": [
    {
      "id": 113178,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-06-01",
      "transaction_shares": "250",
      "transaction_price": "736.0",
      "transaction_type": "S",
      "shares_after_transaction": "20553"
    },
    {
      "id": 113225,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-06-01",
      "transaction_shares": "2",
      "transaction_price": "730.03",
      "transaction_type": "S",
      "shares_after_transaction": "18945"
    },
    {
      "id": 113223,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2023-05-15",
      "transaction_shares": "53807",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 113163,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2023-05-09",
      "transaction_shares": "1326",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "59421"
    },
    {
      "id": 113235,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-01",
      "transaction_shares": "16",
      "transaction_price": "802.67",
      "transaction_type": "S",
      "shares_after_transaction": "19031"
    },
    {
      "id": 113173,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2023-04-21",
      "transaction_shares": "3070",
      "transaction_price": "520.01",
      "transaction_type": "M",
      "shares_after_transaction": "4317"
    },
    {
      "id": 72317,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-04-03",
      "transaction_shares": "7",
      "transaction_price": "816.58",
      "transaction_type": "S",
      "shares_after_transaction": "19140"
    },
    {
      "id": 72338,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-04-03",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "21903"
    },
    {
      "id": 72339,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2023-04-03",
      "transaction_shares": "259",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "125493"
    },
    {
      "id": 113230,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-04-03",
      "transaction_shares": "7",
      "transaction_price": "816.58",
      "transaction_type": "S",
      "shares_after_transaction": "19140"
    },
    {
      "id": 113253,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-04-03",
      "transaction_shares": "1100",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "21903"
    },
    {
      "id": 113254,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "VAGELOS P ROY",
      "reporting_owner_cik": "0001013064",
      "reporting_owner_position": null,
      "transaction_date": "2023-04-03",
      "transaction_shares": "259",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "125493"
    }
  ]
}